The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Mania 2
METHYLPREDNISOLONE. Maternal exposure before pregnancy 2
METHYLPREDNISOLONE. Maternal exposure timing unspecified 2
METHYLPREDNISOLONE. Medial tibial stress syndrome 2
METHYLPREDNISOLONE. Mental status changes 2
METHYLPREDNISOLONE. Mucosal ulceration 2
METHYLPREDNISOLONE. Muscle disorder 2
METHYLPREDNISOLONE. Myalgia 2
METHYLPREDNISOLONE. Nasal ulcer 2
METHYLPREDNISOLONE. Necrotising retinitis 2
METHYLPREDNISOLONE. Nephrolithiasis 2
METHYLPREDNISOLONE. Neurotoxicity 2
METHYLPREDNISOLONE. Normal newborn 2
METHYLPREDNISOLONE. Obesity 2
METHYLPREDNISOLONE. Oropharyngeal candidiasis 2
METHYLPREDNISOLONE. Oxygen saturation decreased 2
METHYLPREDNISOLONE. Palpitations 2
METHYLPREDNISOLONE. Pancreatic carcinoma 2
METHYLPREDNISOLONE. Periostitis 2
METHYLPREDNISOLONE. Peripheral T-cell lymphoma unspecified 2

Total Records: 857     Number of Pages: 43